{
    "pmcid": "11551432",
    "qa_pairs": {
        "How does increasing the surface height of ACE2 affect its ability to mediate cell fusion and virus infection?": [
            "It diminishes its ability to mediate cell fusion and virus infection.",
            "It enhances its ability to mediate cell fusion and virus infection.",
            "It has no effect on its ability to mediate cell fusion and virus infection.",
            "It causes ACE2 to detach from the cell membrane, preventing infection."
        ],
        "What is the significance of the receptor binding domain (RBD) of the SARS-CoV-2 spike protein in the context of virus infection according to the study?": [
            "It must be in close proximity to the cell membrane to facilitate effective virus-mediated cell fusion and infection.",
            "It is responsible for the virus's ability to evade the host immune system.",
            "It determines the virus's ability to replicate within host cells.",
            "It is the primary determinant of the virus's stability in the external environment."
        ],
        "What novel application does the study propose for soluble receptors in the context of virus-based applications?": [
            "Using them to confer viral susceptibility to otherwise resistant cells.",
            "Employing them to enhance the replication rate of the virus in host cells.",
            "Utilizing them to increase the mutation rate of the virus for vaccine development.",
            "Applying them to reduce the virus's ability to bind to host cells."
        ],
        "What potential risk is associated with RBD-targeting antiviral agents as highlighted by the study?": [
            "They could potentially facilitate virus infection when attached to the cell surface.",
            "They might cause an overactive immune response leading to tissue damage.",
            "They could lead to the development of resistant virus strains.",
            "They might interfere with the normal physiological functions of ACE2."
        ],
        "Which type of nanobodies does the study suggest should be the focus for therapeutic applications against SARS-CoV-2?": [
            "Nanobodies targeting the RBD of the spike protein.",
            "Nanobodies targeting the N-terminal domain (NTD) of the spike protein.",
            "Nanobodies targeting the S2 subunit of the spike protein.",
            "Nanobodies targeting the cytoplasmic tail of the spike protein."
        ]
    }
}